Michael Casner

FDA investigator

Appears on 3 documents from 2019 to 2023, most often at sites in India. Most often cites general requirements (21 CFR 211.160).

3
Documents on file
3.0
Observations per 483
2019
First seen
2023
Most recent

What they cite most

From 9 observations

Activity by year

2019: 1, 2020: 1, 2023: 1

Where

India 1 · New Jersey 1 · Pennsylvania 1

Often inspects with

Sneha Patel

Is Michael Casner coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

3 documents, newest first
FirmOpen
483 B & J GroupOct 2, 2023 · Morrisville, Pennsylvania
483 Hetero Drugs LimitedFeb 14, 2020 · Sangareddy district, India
483 AAA Pharmaceutical, Inc.Apr 3, 2019 · Lumberton, New Jersey

About this profile

What does Michael Casner inspect?

Michael Casner appears on 3 documents on file covering 3 sites, most often in India.

What do they cite most often?

21 CFR 211.160 (general requirements), followed by 21 CFR 211.100(a) and 21 CFR 211.166(a).

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Michael Casner is dated Oct 2, 2023.